基于健康保险数据无法评估德国皮肤癌筛查的死亡率:一项病例对照研究
该研究利用德国AOK健康保险数据,对2015-2016年因皮肤黑色素瘤死亡的35-99岁参保人进行病例对照分析,匹配10名对照,通过账单代码01745和01746重建筛查史。结果显示对照组的累积筛查率随时间上升,而病例组在2009年已较高且无单调增加趋势。作者认为仅用保险数据无法进行死亡率评估,因账单代码也用于机会性诊断检查,需与筛查医生和癌症登记数据个体链接。
要点
- 共纳入1037例黑色素瘤死亡病例和10370名对照。
- 对照组累积筛查率从2009年男性13.5%、女性12.5%升至2015年男性52.1%、女性55.1%。
- 病例组筛查率在2009年已较高且无单调增加趋势。
核心结论
- 仅用健康保险数据无法进行皮肤癌筛查的死亡率评估,因账单代码也用于机会性诊断检查,需与筛查医生和癌症登记数据个体链接。
研究设计与样本
- 基于德国AOK健康保险数据的病例对照研究,纳入2015-2016年因皮肤黑色素瘤死亡的35-99岁参保人,每例匹配10名对照,通过账单代码01745和01746重建筛查史。
主要发现
- 共纳入1037例黑色素瘤死亡病例和10370名对照。
- 对照组累积筛查率随时间上升:男性2009年13.5%、2015年52.1%;女性2009年12.5%、2015年55.1%。
- 病例组累积筛查率在2009年已较高,且随诊断年份无单调增加趋势。
- 1037例死亡病例中,224例(21.6%)在诊断后12个月内至少有一次筛查结算。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this paper was to perform a mortality evaluation of skin cancer screening (SCS) in Germany using General Local Health Insurance Fund (AOK) data. METHODS: AOK-insured men and women aged 35-99 years who died of cutaneous malignant melanoma in 2015-2016 were identified. Controls were AOK-insured people who survived to the end of each case's year of death. For each case, 10 controls were matched. The SCS history of each individual was reconstructed using the billing codes 01745 and 01746. RESULTS: In total, 1037 melanoma deaths and 10,370 controls were included. Cumulative SCS prevalence increased among controls over calendar years, as expected (males and females, 2009: 13.5% and 12.5%; 2015: 52.1% and 55.1%). In contrast, among cases, cumulative SCS prevalence was already high in 2009 and did not show a monotonic increase over the years of diagnosis. Of the 1037 melanoma deaths, 224 (21.6%) had at least one SCS settled in the 12 months after diagnosis. DISCUSSION: A mortality evaluation with health insurance data alone is not possible because SCS billing codes are not only used for real SCS but also for occasion-related diagnostic work-up of abnormal skin findings. A mortality evaluation with health insurance data requires an individual linking with data of the screening physician and the cancer registries.
引用
- Stang A, Schuldt K, Trocchi P, et al. The impossibility of mortality evaluation of skin cancer screening in Germany based on health insurance data: a case-control study. Eur J Cancer. 2022. PMID: 35863106. doi:10.1016/j.ejca.2022.06.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。